Samuel Harris is an Editor for the BMC-series and has been the Editor of BMC Psychology since 2019.
Prior to joining BioMed Central, Sam received his PhD in Neuroscience from the Department of Psychology at the University of Sheffield (UK), which was followed by post-doctoral positions at the same institution and the Department of Neurological Surgery at the Weill Cornell Medical College in New York. Sam’s research has focused on the development and application of multimodal techniques in pre-clinical models to investigate neurovascular function during somatosensation and neocortical seizures, and perfusion-related neuroimaging tools. He also worked as a clinical autonomic scientist at the National Hospital for Neurology and Neurosurgery, London, before commencing his doctoral studies.
Keith Laws is Professor of Cognitive Neuropsychology in the School of Life and Medical Sciences at the University of Hertfordshire, UK. He completed a PhD at the Department of Experimental Psychology, University of Cambridge and is the author of over 100 papers and a book entitled 'Category-Specificity: Evidence for Modularity of Mind'. He is a Chartered Psychologist, an Associate Fellow of the British Psychological Society, a Fellow of the Royal Society of Arts, a Fellow of the Institute of Learning and Teaching. He joined to Editorial Board of BMC Psychology as a Section Editor in 2013. He is also currently on the editorial boards of the British Journal of Clinical Psychology, PlosOne and World Journal of Psychiatry.
His research focuses on cognitive functioning in people suffering from neurological and psychiatric disorders including schizophrenia, Alzheimer’s disease, OCD, and body dysmorphic disorder. He has published numerous meta-analyses looking at a wide range of topics including the link between MDMA (ecstasy) drug use and poor memory, the use of ketamine as an antidepressant, sex differences in the cognitive decline associated with Alzheimer’s disease, and whether CBT reduces the symptoms of psychosis. His research has attracted national and international media attention including his work documenting worse cognitive outcomes in women suffering from Alzheimer's disease, better multitasking abilities in women than men, the impact of MDMA (ecstasy) on memory function and the use of Ketamine as an anti-depressant.
Francesco Pagnini (Ph.D. in Clinical Psychology, Psy.D. in Integrated Psychotherapy) is Assistant Professor at Università Cattolica del Sacro Cuore, in Milan, and Associate at Harvard University. His main research interest is the connection between mind and body. In particular, he is interested in studying and developing psychological interventions to help changing the course of physical diseases. He often works with the concepts of mindfulness, flexibility, and openness. He has authored more than 70 articles on peer-reviewed journals, including JAMA, PNAS, Lancet Psychiatry, and Psychological Inquiry, and received several competitive grants from national and international agencies.